Leave Your Message
Discover our flagship medicated pad solutions designed to address bacterial vaginosis and gynecological inflammation — engineered for teens transitioning to adult care and for women seeking daily protection.
The global feminine hygiene market has undergone a transformative evolution over the past two decades. What began as a simple category of menstrual protection products has expanded into a sophisticated, multi-segment industry that bridges pharmaceutical science, biomaterial engineering, and consumer wellness.
Industry analysts project the global medicated and functional feminine pad market to surpass USD 42 billion by 2030, driven largely by increasing awareness of gynecological health among adolescent girls and adult women, rising demand for antibacterial and silver-ion-infused products, and expanding healthcare access across emerging markets in Asia, Africa, and Latin America.
The convergence of pharmaceutical science and feminine hygiene has given rise to medicated pads that deliver active therapeutic ingredients — such as silver ions, herbal extracts, and pH-balancing agents — directly to the vaginal microenvironment. Manufacturers like Shaanxi Wanan Pharmaceutical Co., Ltd. are at the forefront of this pharmaceutical-hygiene crossover, holding dual certifications in both medical device standards (ISO 13485:2003) and quality management systems (ISO 9001:2000).
Silver-ion technology has emerged as the gold standard in antibacterial feminine care. Unlike conventional pads that merely absorb, silver-ion-infused pads actively inhibit the growth of harmful bacteria such as Gardnerella vaginalis — a primary cause of bacterial vaginosis (BV). The Zimeishu silver-ion gynecological pad leverages this technology to provide both preventive and therapeutic benefits, making it uniquely positioned as a pad for teens entering puberty as well as for adult women managing recurring gynecological conditions.
China has emerged as the world's largest manufacturer and exporter of feminine hygiene products. With advanced production facilities, cost-competitive manufacturing, and increasingly stringent quality controls, Chinese suppliers like Wanan Pharmaceutical are capturing growing shares of international B2B markets. Pharmaceutical-grade pads designed for teens and adult women are now exported to Southeast Asia, the Middle East, Eastern Europe, and Africa — regions experiencing rapid growth in feminine health awareness and disposable income.
The rise of e-commerce platforms and digital health ecosystems has fundamentally changed how pads for teens and adult women are marketed and sold. Direct-to-consumer models, subscription-based delivery services, and telehealth partnerships are enabling manufacturers to reach end-users with greater precision. Data-driven product personalization — recommending specific pad formulations based on a user's reported symptoms, age, or menstrual cycle data — represents the next frontier in this industry.
Proprietary silver-ion infusion technology actively neutralizes harmful bacteria and fungi, providing up to 99.9% antibacterial efficacy — clinically validated for both preventive daily use and targeted BV treatment.
Certified under ISO 9001:2000 (Quality Management) and ISO 13485:2003 (Medical Devices), Zimeishu pads meet the highest international standards for safety, efficacy, and manufacturing consistency.
Formulated with skin-safe, hypoallergenic materials suitable for adolescent girls experiencing their first years of menstruation, while providing the therapeutic strength required by adult women managing chronic gynecological conditions.
Advanced formulations help maintain the natural vaginal pH balance (3.8–4.5), supporting a healthy Lactobacillus-dominant microbiome — critical for long-term gynecological wellness at every life stage.
Produced in a GMP-compliant pharmaceutical facility with over RMB 65 million in fixed assets, supported by a 70+ member gynecological expert advisory group ensuring every production batch meets clinical-grade standards.
With an annual export capacity exceeding USD 6 million and established logistics networks across Asia, the Middle East, and beyond, Wanan Pharmaceutical delivers consistent supply reliability for international B2B partners.
Beyond basic menstrual protection, medicated gynecological pads serve a diverse spectrum of clinical, institutional, and consumer use cases that span the full arc of a woman's reproductive life.
Educational institutions are increasingly incorporating medicated feminine pads into adolescent health curricula and school nurse dispensaries, ensuring teen girls have access to antibacterial protection during their formative years.
Physicians and gynecologists recommend Zimeishu-type medicated pads as adjunct therapy for patients recovering from BV treatment, post-surgical care, or managing recurrent vulvovaginal candidiasis.
Pharmacies and online health platforms position medicated teen-to-adult pads as premium wellness products, commanding higher margins and customer loyalty through subscription and bundle models.
Progressive corporations in Asia and beyond are integrating feminine hygiene product programs — including medicated pads — into employee wellness packages, recognizing the productivity impact of gynecological health.
Non-governmental organizations operating in developing regions are sourcing factory-direct medicated pads from China suppliers to address menstrual hygiene management (MHM) gaps and reduce gynecological infection rates among underserved populations.
Silver-ion feminine pads are increasingly featured in peer-reviewed gynecological and dermatological research as both study subjects and control materials, validating their therapeutic role and driving further product innovation.
The feminine pad industry is at an inflection point. Emerging technologies and shifting consumer values are converging to redefine what a pad for teens and adult women can — and should — do.
Machine learning algorithms are being deployed to analyze menstrual cycle data, symptom reports, and lifestyle factors to recommend personalized pad formulations — from absorbency levels to antibacterial concentrations — for individual users at different life stages.
Environmental consciousness is driving R&D investment in plant-based, biodegradable pad substrates that maintain antibacterial efficacy while dramatically reducing the ecological footprint of feminine hygiene products — a key purchasing criterion for Gen Z and millennial women.
Next-generation medicated pads are being engineered to deliver pharmaceutical compounds transdermally — including antifungal agents, hormonal micro-doses, and probiotic formulations — transforming the pad from a passive hygiene product into an active therapeutic device.
Founded in 1995, Shaanxi Wanan Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise integrating scientific research, production, and sales. With fixed assets of approximately RMB 65 million Yuan (about USD 8 million) and an annual sales volume exceeding RMB 50 million Yuan (about USD 6 million), Wanan Pharmaceutical currently employs over 300 staff — 50% of whom are medical professionals.
The company's research capabilities are anchored by a scientific research group comprising 5 medical doctors and 11 masters, and an expert advisory group of more than 70 gynecological doctors. This depth of clinical expertise directly informs every product formulation and quality control protocol.
Zimeishu silver-ion gynecological pad is Wanan's flagship product, demonstrating prominent efficacy in preventing and treating gynecological inflammations. The product has passed both ISO 9001:2000 and ISO 13485:2003 international certifications. Today, Wanan's sales network extends across most major and mid-tier cities in China, earning the trust of over 6 million women.
Adhering to the core philosophy of "Working with credibility and seeking for perfection", Wanan's dedicated team — with Zimeishu as the carrier of their passion — continues to make meaningful contributions to the health and quality of life of women worldwide.
Explore the complete Zimeishu medicated pad collection — factory-direct, ISO-certified, and engineered for every stage of a woman's gynecological wellness journey.
Whether you are a global distributor, a healthcare institution, or a brand seeking OEM/ODM feminine hygiene solutions, Shaanxi Wanan Pharmaceutical Co., Ltd. offers the clinical expertise, manufacturing scale, and international certifications to be your trusted supply partner.
Get In Touch NowIn order to improve the life quality of women worldwide, the staffs of Wanan — adhering to the conception of "Working with credibility and seeking for perfection" — taking "Zimeishu" as the carrier of their deep passion, will surely make contribution to the health of women at every stage of life, from teens to adult women and beyond.
Send Inquiry →